Eqwal Care
0707.608.763 · rovalta.com · 24/09/2026
ACTIVE
Eqwal Care
Financial year 2025 · Closed on 30/09/2025
Net result
935,9 k €
+73,7 %over 1 yearGross margin
4,6 M €
+21,6 %over 1 yearEquity
2,1 M €
-19,8 %over 1 yearWorkforce
24,5 ETP
+0,4 %over 1 yearOverview
Identity
Source · BCE/KBOEqwal Care is a Public limited company incorporated in 2018. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 24,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0707.608.763
- Incorporation
- 02/10/2018
- Legal form
- Public limited company
- Registered office
- Herman Teirlinckstraat 15
9041 Gent · FlandreSee on map - Contributed capital
- 1 894 011,00 €
- Latest accounts
- 30/09/2025
- Average workforce
- 24,5 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods47740Retail sale of medical and orthopaedic goods in specialised stores47741Retail sale of medical and orthopaedic goods in specialised stores46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods+2
Joint committees (1)
- 340
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 4,6 M € | +21.6% | 3,8 M € | -8.7% | 4,1 M € | – | – | ||
| EBITDA | 2,1 M € | +21.5% | 1,7 M € | -2.4% | 1,7 M € | +66.1% | 1 M € | -29.1% | 1,5 M € |
| Operating result | 1,3 M € | +65.0% | 787,7 k € | -2.7% | 809,5 k € | +587% | 117,9 k € | -83.7% | 721,6 k € |
| Net result | 935,9 k € | +73.7% | 538,7 k € | +8.6% | 496 k € | +2479% | -20,8 k € | -104% | 554,5 k € |
| Balance sheet | |||||||||
| Equity | 2,1 M € | -19.8% | 2,7 M € | -31.2% | 3,9 M € | +14.6% | 3,4 M € | -0.6% | 3,4 M € |
| Total assets | 6,1 M € | -8.4% | 6,7 M € | +9.7% | 6,1 M € | -20.7% | 7,6 M € | +28.4% | 6 M € |
| Cash | 588,4 k € | +7.0% | 549,9 k € | +1096% | 46 k € | +883% | 4,7 k € | -99.2% | 550,3 k € |
| Debts | 4 M € | -0.1% | 4 M € | +84.6% | 2,1 M € | -49.1% | 4,2 M € | +68.5% | 2,5 M € |
| Other | |||||||||
| Workforce | 24,5 ETP | +0.4% | 24,4 ETP | +3.0% | 23,7 ETP | +6.3% | 22,3 ETP | -3.0% | 23,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20233 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
Herman Teirlinckstraat 15 9041 Gent| Company | CBE no. |
|---|---|
Eqwal● Active | 0426.419.720 |
Eqwal Roeselare● Active | 0450.255.093 |
Eqwal Stomacare● Active | 0849.873.517 |
FINICOMA● Active | 0668.547.457 |
Nixa-Phone● Liquidation | 0827.622.410 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Full model | Full model | Full model |
| Start of the financial year | 01/10/2024 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 9 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/04/2026 | 22/04/2025 | 03/09/2024 | 03/07/2023 | 14/07/2022 | 08/07/2021 |
| General meeting | 13/03/2026 | 19/03/2025 | 19/07/2024 | 30/06/2023 | 29/06/2022 | 28/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 13/03/2026 | 21/04/2026 | Dutch | |
| Abridged model | 30/09/2024 | 19/03/2025 | 22/04/2025 | Dutch | |
| Abridged model | 31/12/2023 | 19/07/2024 | 03/09/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 03/07/2023 | Dutch | |
| Full model | 31/12/2021 | 29/06/2022 | 14/07/2022 | Dutch | |
| Full model | 31/12/2020 | 28/06/2021 | 08/07/2021 | Dutch | |
| Full model | 31/12/2019 | 11/09/2020 | 29/10/2020 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20233 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring08/06/2026KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring22/05/2026KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Other19/02/2026DIVERSEN
- Other20/11/2025DIVERSEN
- Other15/10/2025BENAMING
- Restructuring13/08/2025DOEL - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Other18/06/2025DIVERSEN
- Mandates30/05/2025ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025935,9 k €↑
- 2025Name changeEqwal Care
- 2024Annual accounts 2024538,7 k €↑
- 2023Annual accounts 2023496 k €↑
- 2023Name changeAqtor! Care
- 2022Annual accounts 2022-20,8 k €↓
- 2021Annual accounts 2021554,5 k €↑
- 2020Annual accounts 202040,4 k €↓
- 2019Annual accounts 2019640,6 k €
- 2019Name changeArseus Banda
- 02/10/2018IncorporationPublic limited company